Organon & Co. (NYSE:OGN) finished Friday with an addition of $0.28 to close at $17.36, an upside of 1.64 percent. An average of 4,449,460 shares of common stock have been traded in the last five days. There was a fall of -$0.90 in the past week, and it reached a new high 22 times over the past 12 months. The last 20 days have seen an average of 3,164,495 shares traded, while the 50-day average volume stands at 2,496,838.
OGN stock has decreased by -22.22% in the last month. The company shares reached their 1-month lowest point of $16.42 on 09/28/23. With the stock rallying to its 52-week high on 01/18/23, shares of the company touched a low of $16.42 and a high of $32.43 in 52 weeks. It has reached a new high 10 times so far this year and lost -37.84% or -$10.57 in price. In spite of this, the price is down -46.47% from the 52-week high.
Valuation Metrics
Organon & Co. (OGN) has a trailing price-to-earnings (P/E) ratio of 5.89. The stock’s beta is 0.88. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.72, and the price-to-cash flow ratio at 9.05.
Financial Health
The quick ratio of Organon & Co. for the recent quarter was 1.16, and the current ratio was 1.66, indicating that the company is able to meet its debt obligations. Its gross profit as reported stood at $3.88 billion compared to revenue of $6.17 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Organon & Co.’s return on assets was 6.98%.
Earnings Surprise
For the recent quarter, Organon & Co. had $8.72 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $242.0 million in the quarter, while revenues were grew 3.31%. Shareholders own equity worth $255.57 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Organon & Co. (OGN) price momentum. RSI 9-day as of the close on 29 September was 29.92%, suggesting the stock is oversold, with historical volatility in this time frame at 32.31%.
As of today, OGN’s price is $17.23 -4.93% or -$0.90 from its 5-day moving average. OGN is currently trading -20.95% lower than its 20-day SMA and -20.44% lower than its 100-day SMA. However, the stock’s current price level is -16.94% below the SMA50 and -37.06% below the SMA200.
The stochastic %K and %D were 15.95% and 8.87%, respectively, and the average true range (ATR) was 0.54. With the 14-day stochastic at 27.30% and the average true range at 0.54, the RSI (14) stands at 30.06%. The stock has reached -0.87 on the 9-day MACD Oscillator while the 14-day reading was at -1.45.
Analyst Ratings
Barclays launched coverage on Organon & Co. (NYSE: OGN) in its analyst report released on September 21, 2023. The firm assigned the stock an Overweight rating.
